Ameritas Investment Partners, Inc. - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 231 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$13,294
-50.3%
16,2120.0%0.00%0.0%
Q4 2022$26,750
-0.9%
16,2120.0%0.00%0.0%
Q3 2022$27,000
-3.6%
16,2120.0%0.00%0.0%
Q2 2022$28,000
-51.7%
16,2120.0%0.00%
-50.0%
Q1 2022$58,000
-28.4%
16,2120.0%0.00%
-33.3%
Q4 2021$81,000
-30.2%
16,2120.0%0.00%
-25.0%
Q3 2021$116,000
-22.7%
16,2120.0%0.00%
-20.0%
Q2 2021$150,000
+7.1%
16,212
+7.6%
0.01%0.0%
Q1 2021$140,000
+17.6%
15,065
+11.6%
0.01%0.0%
Q4 2020$119,000
-23.7%
13,4980.0%0.01%
-28.6%
Q3 2020$156,000
-54.9%
13,498
+5.1%
0.01%
-56.2%
Q2 2020$346,000
+467.2%
12,848
+55.6%
0.02%
+433.3%
Q1 2020$61,000
+165.2%
8,259
+19.0%
0.00%
+200.0%
Q4 2019$23,000
+64.3%
6,9410.0%0.00%0.0%
Q3 2019$14,000
-30.0%
6,9410.0%0.00%0.0%
Q2 2019$20,000
-23.1%
6,9410.0%0.00%0.0%
Q1 2019$26,000
-7.1%
6,9410.0%0.00%
-50.0%
Q4 2018$28,000
-28.2%
6,9410.0%0.00%0.0%
Q3 2018$39,000
+44.4%
6,9410.0%0.00%
+100.0%
Q2 2018$27,000
-18.2%
6,9410.0%0.00%
-50.0%
Q1 2018$33,000
+13.8%
6,9410.0%0.00%
+100.0%
Q4 2017$29,000
-9.4%
6,941
+28.8%
0.00%
-50.0%
Q3 2017$32,000
-23.8%
5,3910.0%0.00%0.0%
Q2 2017$42,000
+16.7%
5,3910.0%0.00%0.0%
Q1 2017$36,0005,3910.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
CAXTON ASSOCIATES LP 784,679$643,4370.10%
Green Alpha Advisors, LLC 146,300$119,9660.08%
Virtus ETF Advisers LLC 54,106$44,3670.02%
Cedar Brook Financial Partners, LLC 104,881$86,0020.02%
Arlington Capital Management, Inc. 27,735$22,7430.02%
PROFUND ADVISORS LLC 418,749$343,3740.02%
Hennion & Walsh Asset Management, Inc. 382,158$3130.02%
Rafferty Asset Management, LLC 2,647,927$2,171,3000.02%
Brainard Capital Management LLC 16,666$13,6660.01%
E Fund Management Co., Ltd. 129,289$1060.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders